Oral fluoroquinolones and risk of secondary pseudotumor cerebri syndrome: Nested case-control study

Conclusion: Our study suggests an increase in the risk of PTCS with current users of fluoroquinolones. Although this adverse event is rare, patients who experience symptoms of raised intracranial pressure including headaches, tinnitus, and double vision while taking fluoroquinolones should seek medical attention.
Source: Neurology - Category: Neurology Authors: Tags: Idiopathic intracranial hypertension, Case control studies ARTICLE Source Type: research